Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AbbVie presents new TRPV1 antagonists for pain and other disorders

July 17, 2013

First-in-human results presented for LY-2951742

July 17, 2013

Pfizer synthesizes new sodium channel blockers

July 16, 2013

Biogen presents in vivo and phase I pharmacokinetic results for BIIB-037

July 16, 2013

Dart Therapeutics begins phase Ib/IIa study of HT-100

July 16, 2013

Intellipharmaceutics provides updates on Rexista oxycodone technology development

July 16, 2013

Clinical data presented on Upsher-Smith's drug formulations for epilepsy

July 16, 2013

Novel potassium channel opener discovered at SciFluor Life Sciences

July 16, 2013

Promising first data for AbbVie compound in mild to moderate Alzheimer's disease

July 15, 2013

FDA and EMA issue decisions regarding C-Path's trial simulation tool for Alzheimer's disease

July 15, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...